瑛泰醫療(01501.HK)擬攜手辰躍維新收購杭州唯強醫療科技81.83%股權
瑛泰醫療(01501.HK)公吿,於2025年5月21日,公司、辰躍維新、目標公司、開曼公司、香港公司及創始股東已訂立正式收購協議,據此,公司及辰躍維新(作為買方)有條件同意向香港公司(作為賣方)收購目標公司杭州唯強醫療科技合計81.83%的股權,總代價約為人民幣512.84百萬元,其中公司將收購目標公司51.70%股權的控股權益,代價約為人民幣324.04百萬元,惟須待完成或豁免先決條件後方可作實。
於完成後,目標公司將成為公司的非全資子公司,且於目標公司成為公司的非全資子公司後,公司及辰躍維新(作為買方)將向目標公司進一步注資不少於人民幣150.00百萬元。
辰躍維新主要從事企業管理及企業管理諮詢。辰躍維新由辰耀新晨全資擁有,而辰耀新晨由上海科技創業投資股份有限公司管理,上海科技創業投資股份有限公司由上海科技創業投資有限公司擁有約62.30%權益,上海科技創業投資有限公司由上海市國有資產監督管理委員會最終擁有。上海科投股份其他八位股東概無持有上海科投股份30%或以上股權。
目標公司主要從事主動脈及外周血管介入醫療器械的研究、開發、製造及銷售。由於主動脈及外周血管介入╱植入乃公司產業佈局的重要領域之一,公司建議收購目標公司可進一步完善公司在主動脈及外周血管介入及植入領域的產品佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.